Microcystic and Macrocystic Lymphatic Malformations: Distinct Genetics and Clinical Strategies
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Objective(s): To review the classification, genetics, diagnosis, and management of lymphatic malformations (LMs), emphasizing the clinical and therapeutic differences between macrocystic and microcystic subtypes to guide targeted treatment and subtype-specific clinical trial design. Methods: Narrative review synthesizing current literature on LM epidemiology, pathophysiology, imaging, histopathology, and treatments, including sclerotherapy, surgery, laser therapy, and targeted agents. Results: LMs are driven mainly by postzygotic PIK3CA mutations activating the phosphoinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR) pathway. Macrocystic LMs (>2 cm cysts) present as compressible masses, respond well to sclerotherapy, and allow radiologic volume assessment. Microcystic LMs (
Fields of Study & Subjects
Vascular Malformations and Hemangiomas
Lymphatic System and Diseases
Lymphatic Disorders and Treatments
Publication details
- Journal / source
- Journal of Vascular Anomalies
- Volume
- 7
- Issue
- 2
- Pages
- e133–e133
- Publication date
- 24 March 2026
- Language
- EN